51³Ô¹ÏÍø

Deucravacitinib psoriasis drug, illustration - stock illustration

Illustration of Deucravacitinib (BMS-986165) bound to its target protein. Deucravacitinib is a tyrosine kinase 2 (TYK2) inhibitor used in the treatment of psoriasis
Illustration of Deucravacitinib (BMS-986165) bound to its target protein. Deucravacitinib is a tyrosine kinase 2 (TYK2) inhibitor used in the treatment of psoriasis
Deucravacitinib psoriasis drug, illustration
Get this image in a variety of framing options at Photos.com.
PURCHASE A LICENSE
All Royalty-Free licenses include global use rights, comprehensive protection, simple pricing with volume discounts available
€300.00
EUR
Getty ImagesDeucravacitinib Psoriasis Drug Illustration High-Res Vector GraphicDeucravacitinib Psoriasis Drug Illustration High-Res Vector GraphicDownload premium, authentic Deucravacitinib psoriasis drug, illustration stock illustrations from 51³Ô¹ÏÍø Explore similar high-resolution stock illustrations in our expansive visual catalogue.Product #:2172899593
€300€40
Getty Images
In stock

DETAILS

Credit:
BEHNOUSH HAJIAN/SCIENCE PHOTO LIBRARY
51³Ô¹ÏÍø #:
2172899593
License type:
Royalty-free
Collection:
Science Photo Library
Max file size:
6750 x 3796 px (22.50 x 12.65 in) - 300 dpi - 13 MB
Upload date:
Release info:
No release required
Categories: